Israel Active

MultiGeneAngio from Israel’s VESSL Therapeutics is in human trials for treating peripheral and coronary artery disease. The patient’s cells are extracted, enhanced with genes and re-implanted, to increase blood flow to oxygen-starved muscles. And VESSL’s MultiGeneGraft treats end-stage renal disease.  

Israel’s AIVF (see previously) has received the CE Mark for its unique AI IVF analysis platform that avoids risky biopsies. AIVF’s system improves the success of IVF treatment – a costly and invasive process. US approval is now also being sought.

Scientists at Israel’s Technion Institute have new technology for bone and soft tissue repair. Instead of grafting bone from elsewhere in the body, they used stem cells from the soft tissue inside discarded teeth. They then combined this with other cells to repair spinal cord in laboratory tests.

Researchers from Tel Aviv University have developed an Artificial Intelligence platform that can identify the specific proteins that allow bacteria to infect the intestines. It should lead to new therapeutics that can neutralize the proteins and prevent disease, eliminating the use of antibiotics.

Israel’s Tamar Robotics (see previously) is developing a surgical robot to revolutionize brain surgery. It will give doctors a minimally invasive tool to remove tumors and blood clots and treat other brain conditions that now require major surgery. See video of founder Professor Shohan.

In recent trials at Israel’s Sheba Medical Center, the Taffix nose spray from Israel’s Nasus (see previously) blocked 100 percent” of the British and South African variants of SARS-CoV-2 virus.

A study by Israel’s Sheba Medical Center has concluded that the wearing of facemasks protected many citizens not only from Covid-19 but also from asthma and allergies. Urgent visits to Sheba’s emergency unit during the pandemic by asthma patients dropped by 49% and hospitalizations by 65%.

5 million Israelis have now received two Covid vaccinations – 80% of the adult population. And a new study shows that vaccinations have saved some 6,000 Israeli lives. Finally, Israel’s Beilinson hospital has discharged all its 257 mothers, infected while pregnant, now with their healthy babies.

Scientists at Tel Aviv University have developed new optical technology that will enable an immediate, non-invasive diagnosis of melanoma, a form of skin cancer. Special optical fibers can distinguish between benign and malignant lesions on the skin, potentially saving many patients’ lives.

A two-year-old Arab boy with chronic heart problems, fell unconscious at his home in Deir el-Asad, northern Israel. Four EMTs (Muslims and Jews) from Israel’s United Hatzalah managed to get his pulse back and transported him and his mother to Haifa’s Rambam hospital.